In this study, we examined the relationship between CCNG2 and the malignancy of astrocytomas and whether the AKT pathway, which is upregulated in astrocytomas, may inhibit CCNG2 expression. Here, CCNG2 is linked to astrocytoma (excluding glioblastoma).